The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

Woodworth, Kate R.; Moulia, Danielle; Collins, Jennifer P.; Hadler, Stephen C.; Jones, Jefferson M.; Reddy, Sujan C.; Chamberland, Mary; Campos-Outcalt, Doug; Morgan, Rebecca L.; Brooks, Oliver; Talbot, H. Keipp; Lee, Grace M.; Bell, Beth P.; Daley, Matthew F.; Mbaeyi, Sarah; Dooling, Kathleen; Oliver, Sara E.

doi:10.15585/MMWRmm7045e1

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

11 12 2021
By Woodworth, Kate R. ; Moulia, Danielle ; Collins, Jennifer P. ; ...
http://dx.doi.org/10.15585/MMWRmm7045e1
Source: MMWR Morb Mortal Wkly Rep. 70(45):1579-1583

[PDF-216.11 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

MMWR Morb Mortal Wkly Rep
Personal Author:

Woodworth, Kate R. ; Moulia, Danielle ; Collins, Jennifer P. ; Hadler, Stephen C. ; Jones, Jefferson M. ; ... More +

Woodworth, Kate R. ; Moulia, Danielle ; Collins, Jennifer P. ; Hadler, Stephen C. ; Jones, Jefferson M. ; Reddy, Sujan C. ; Chamberland, Mary ; Campos-Outcalt, Doug ; Morgan, Rebecca L. ; Brooks, Oliver ; Talbot, H. Keipp ; Lee, Grace M. ; Bell, Beth P. ; Daley, Matthew F. ; Mbaeyi, Sarah ; Dooling, Kathleen ; Oliver, Sara E. Less -
Description:

The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine is a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine encoding the prefusion spike glycoprotein of SARS-CoV-2, the Virus that causes COVID-19. On August 23, 2021, the Food and Drug Administration (FDA) approved a Biologics License Application (BLA) for use of the Pfizer-BioNTech COVID-19 Vaccine, marketed as Comirnaty (Pfizer, Inc.), in persons aged ≥16 years (1). The Pfizer-BioNTech COVID-19 Vaccine is also recommended for adolescents aged 12-15 years under an Emergency Use Authorization (EUA) (1). All persons aged ≥12 years are recommended to receive 2 doses (30 μg, 0.3 mL each), administered 3 weeks apart (2,3). As of November 2, 2021, approximately 248 million doses of the Pfizer-BioNTech COVID-19 Vaccine had been administered to persons aged ≥12 years in the U.S.* On October 29, 2021, FDA issued an EUA amendment for a new formulation of Pfizer-BioNTech COVID-19 Vaccine for use in children aged 5-11 years, administered as 2 doses (10 μg, 0.2 mL each), 3 weeks apart (Table) (1). On November 2, 2021, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation| for use of the Pfizer-BioNTech COVID-19 Vaccine in children aged 5-11 years for the Prevention of COVID-19. To guide its deliberations regarding Rec.for the vaccine, ACIP used the Evidence to Recommendation (EtR) Framework| and incorporated a Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.| The ACIP recommendation for the use of the Pfizer-BioNTech COVID-19 Vaccine in children aged 5-11 years under an EUA is interim and will be updated as additional information becomes available. The Pfizer-BioNTech COVID-19 Vaccine has high efficacy (>90%) against COVID-19 in children aged 5-11 years, and ACIP determined benefits outweigh risks for vaccination. Vaccination is important to protect children against COVID-19 and reduce community Transmission of SARS-CoV-2.
Subjects:

[+]

Advisory Committees Child CoronaVirus Infections COVID-19 COVID-19 Vaccines Drug Approval Humans Immunization Immunization Schedule Practice Guidelines As Topic
Source:

MMWR Morb Mortal Wkly Rep. 70(45):1579-1583
Pubmed ID:

34758012
Pubmed Central ID:

PMC8580204
Document Type:

Journal Article
Name as Subject:

Centers for Disease Control and Prevention (U.S.) ; U.S.Food and Drug Administration. ; Pfizer-BioNTech COVID-19 Vaccine ; Centers for Disease Control and Prevention (U.S.) ; U.S.Food and Drug Administration. ; ... More +

Centers for Disease Control and Prevention (U.S.) ; U.S.Food and Drug Administration. ; Pfizer-BioNTech COVID-19 Vaccine ; Centers for Disease Control and Prevention (U.S.) ; U.S.Food and Drug Administration. ; Pfizer-BioNTech COVID-19 Vaccine Less -
Place as Subject:

U.S.
Volume:

70
Issue:

45
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha256:8cf75410d70d9bc08bc81ec47802e27ae2ca824ef09392a62aaf0e2d7fdc7a9b
Download URL:

https://stacks.cdc.gov/view/cdc/111856/cdc_111856_DS1.pdf
File Type:

mm7045e1.nxml

xml

More +